Tag: Tirzepatide
-
Tirzepatide Dosage Guide: Titration Schedules and Administration
Complete guide to tirzepatide dosing across approved indications. Explains the step-by-step 4-week titration protocol from 2.5 mg to 15 mg, device handling (KwikPen vs vials), maintenance targets and rules for missed injections.
-
Managing GLP-1 Side Effects: Nausea, Constipation and GI Tolerability
Gastrointestinal symptoms affect 40% to 70% of patients initiating GLP-1 receptor agonists. Here is the evidence on why these adverse effects occur, practical management strategies, and how to recognise rare, serious complications.
-
GLP-1 Medications and Muscle Mass: Preserving Lean Tissue During Weight Loss
When losing significant weight on GLP-1 medicines, between 20% and 40% of total mass lost is lean tissue. We examine clinical trial DEXA findings and evidence-based protocols to preserve skeletal muscle.
-
Orlistat vs GLP-1 Incretins: Comparing Lipase Inhibitors and Receptor Agonists
Orlistat prevents dietary fat absorption in the gut, whereas GLP-1 receptor agonists act centrally to suppress appetite. Here is how their mechanisms, efficacy, tolerability and clinical roles compare.
-
What Happens When Stopping GLP-1 Medicines? Evidence on Weight Regain
Discontinuing GLP-1 receptor agonists leads to substantial weight regain in clinical trials. Here is what the STEP-1 extension and SURMOUNT-4 studies reveal about metabolic adaptation, appetite recovery and long-term weight management.
-
Mounjaro vs Zepbound: Same Tirzepatide, Different Indications
Mounjaro and Zepbound both contain tirzepatide. Learn why they carry different names and indications in the US, and why only Mounjaro is authorised in the UK.
-
GLP-1 vs GIP: How Semaglutide and Tirzepatide Work
GLP-1 and GIP are gut hormones behind semaglutide and tirzepatide. Learn what each receptor does, why tirzepatide is a dual agonist, and what is still unproven.
-
Semaglutide vs Tirzepatide: Understanding the Differences
Compare semaglutide and tirzepatide, including SURMOUNT-5 results, weight-loss outcomes, mechanisms, safety and oral formulations.